Breaking News Instant updates and real-time market news.

FITB

Fifth Third

$37.78 /

+0.89 (+2.41%)

08:34
06/22/21
06/22
08:34
06/22/21
08:34

Fifth Third to acquire digital platform for healthcare practices Provide

Fifth Third Bancorp announced a definitive agreement to acquire Provide, a digital platform for healthcare practices. In 2018, Fifth Third was an early investor in Provide, and the bank began funding loans through the company's platform in 2020. Provide will maintain its brand identity and operate as an independent business line as it continues to scale and expand product offerings for healthcare practices and the doctors who own them nationwide. The acquisition is subject to customary closing conditions, including regulatory approvals. Financial terms of the transaction have not been disclosed. "The healthcare industry is one of the largest and fastest growing segments of the U.S. economy. Over the last decade, Fifth Third's healthcare team has expanded its presence and expertise to become one of the top healthcare banking platforms for middle-market and corporate clients. Together, we can deliver a client experience that enables healthcare providers to focus on what they do best-providing the care their patients need while we make their banking experience convenient and efficient," said Greg Carmichael, chairman and CEO for Fifth Third Bancorp.

  • 22

    Jul

FITB Fifth Third
$37.78 /

+0.89 (+2.41%)

06/03/21 Baird
Fifth Third price target raised to $44 from $39 at Baird
05/03/21 JPMorgan
Fifth Third price target raised to $42 from $38.50 at JPMorgan
04/21/21 Baird
Fifth Third weakness a buying opportunity, says Baird
04/21/21 RBC Capital
Fifth Third price target raised to $42 from $38 at RBC Capital

TODAY'S FREE FLY STORIES

Periodicals
Alzheimer's scientists call Cassava results 'overblown,' STAT says » 07:15
07/30/21
07/30
07:15
07/30/21
07:15
SAVA

Cassava Sciences

$103.29 /

-32.09 (-23.70%)

After Cassava Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAVA Cassava Sciences
$103.29 /

-32.09 (-23.70%)

SAVA Cassava Sciences
$103.29 /

-32.09 (-23.70%)

07/20/21 H.C. Wainwright
Cassava Sciences price target raised to $124 from $97 at H.C. Wainwright
07/15/21
Fly Intel: Top five analyst downgrades
07/15/21 Cantor Fitzgerald
Cassava Sciences downgraded to Neutral from Overweight at Cantor Fitzgerald
06/23/21 B. Riley
Cassava Sciences price target raised to $111 from $78 at B. Riley
SAVA Cassava Sciences
$103.29 /

-32.09 (-23.70%)

  • 13
    Nov
SAVA Cassava Sciences
$103.29 /

-32.09 (-23.70%)

SAVA Cassava Sciences
$103.29 /

-32.09 (-23.70%)

Earnings
WisdomTree reports Q2 adjusted EPS 10c, consensus 9c » 07:14
07/30/21
07/30
07:14
07/30/21
07:14
WETF

WisdomTree

$6.24 /

+0.14 (+2.30%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WETF WisdomTree
$6.24 /

+0.14 (+2.30%)

WETF WisdomTree
$6.24 /

+0.14 (+2.30%)

04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
04/08/21 Morgan Stanley
Morgan Stanley upgrades WisdomTree to Equal Weight on improved growth outlook
04/08/21 Morgan Stanley
WisdomTree upgraded to Equal Weight from Underweight at Morgan Stanley
03/17/21 Northcoast
WisdomTree downgraded to Neutral from Buy at Northcoast
WETF WisdomTree
$6.24 /

+0.14 (+2.30%)

WETF WisdomTree
$6.24 /

+0.14 (+2.30%)

WETF WisdomTree
$6.24 /

+0.14 (+2.30%)

Earnings
Newell Brands backs FY21 normalized EPS view $1.63-$1.73, consensus $1.72 » 07:14
07/30/21
07/30
07:14
07/30/21
07:14
NWL

Newell Brands

$27.23 /

+0.395 (+1.47%)

Raises FY21 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

07/14/21 Raymond James
Newell Brands upgraded to Strong Buy from Market Perform at Raymond James
07/13/21 Raymond James
Newell Brands upgraded to Strong Buy from Market Perform at Raymond James
06/23/21 UBS
Newell Brands initiated with a Buy at UBS
05/03/21 Truist
Newell Brands price target raised to $35 from $30 at Truist
NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

Recommendations
Saia price target raised to $277 from $257 at Wells Fargo » 07:13
07/30/21
07/30
07:13
07/30/21
07:13
SAIA

Saia

$221.31 /

+14.155 (+6.83%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAIA Saia
$221.31 /

+14.155 (+6.83%)

SAIA Saia
$221.31 /

+14.155 (+6.83%)

06/29/21 Truist
Saia price target lowered to $240 from $270 at Truist
06/21/21 Stifel
Saia resumed with a Hold at Stifel
06/18/21
Fly Intel: Top five analyst upgrades
06/18/21 Wells Fargo
Saia upgraded to Overweight from Equal Weight at Wells Fargo
SAIA Saia
$221.31 /

+14.155 (+6.83%)

Upgrade
Gentherm upgraded to Buy from Hold at Craig-Hallum » 07:13
07/30/21
07/30
07:13
07/30/21
07:13
THRM

Gentherm

$81.49 /

+9.35 (+12.96%)

Craig-Hallum analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
THRM Gentherm
$81.49 /

+9.35 (+12.96%)

THRM Gentherm
$81.49 /

+9.35 (+12.96%)

03/02/21 Roth Capital
Gentherm price target raised to $85 from $53 at Roth Capital
01/22/21 JPMorgan
Gentherm downgraded to Underweight on valuation at JPMorgan
01/22/21 JPMorgan
Gentherm downgraded to Underweight from Neutral at JPMorgan
12/23/20 Barrington
Gentherm double downgraded to Underperform at Barrington following rally
THRM Gentherm
$81.49 /

+9.35 (+12.96%)

Earnings
Affimed's AFM24 shows therapeutic potential in EGFR-expressing tumors » 07:13
07/30/21
07/30
07:13
07/30/21
07:13
AFMD

Affimed

$6.82 /

-0.07 (-1.02%)

Affimed announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AFMD Affimed
$6.82 /

-0.07 (-1.02%)

AFMD Affimed
$6.82 /

-0.07 (-1.02%)

04/12/21 BMO Capital
Affimed price target raised to $15 from $12 at BMO Capital
03/30/21 Credit Suisse
Affimed N.V. initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Affimed N.V. initiated with an Outperform at Credit Suisse
03/24/21 Wells Fargo
Affimed N.V. price target raised to $15 from $10 at Wells Fargo
AFMD Affimed
$6.82 /

-0.07 (-1.02%)

  • 13
    Jan
AFMD Affimed
$6.82 /

-0.07 (-1.02%)

Recommendations
LKQ Corp. price target raised to $60 from $54 at Baird » 07:13
07/30/21
07/30
07:13
07/30/21
07:13
LKQ

LKQ Corp.

$51.45 /

+1.5 (+3.00%)

Baird analyst Craig…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LKQ LKQ Corp.
$51.45 /

+1.5 (+3.00%)

LKQ LKQ Corp.
$51.45 /

+1.5 (+3.00%)

04/30/21 Truist
LKQ Corp price target raised to $55 from $48 at Truist
04/30/21 Barrington
LKQ Corp. price target raised to $60 from $50 at Barrington
03/26/21 Stephens
O'Reilly Automotive price target raised to $575, named Best Idea at Stephens
02/19/21 Barrington
LKQ Corp. price target raised to $50 from $40 at Barrington
LKQ LKQ Corp.
$51.45 /

+1.5 (+3.00%)

LKQ LKQ Corp.
$51.45 /

+1.5 (+3.00%)

Hot Stocks
Colgate-Palmolive CEO expects 'difficult cost environment' to continue in 2H21 » 07:13
07/30/21
07/30
07:13
07/30/21
07:13
CL

Colgate-Palmolive

$83.49 /

+0.315 (+0.38%)

Noel Wallace, Chairman,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CL Colgate-Palmolive
$83.49 /

+0.315 (+0.38%)

CL Colgate-Palmolive
$83.49 /

+0.315 (+0.38%)

06/23/21 UBS
Colgate-Palmolive initiated with a Buy at UBS
06/09/21
Fly Intel: Top five analyst upgrades
06/09/21 Credit Suisse
Colgate-Palmolive upgraded to Outperform from Neutral at Credit Suisse
05/03/21 Deutsche Bank
Colgate-Palmolive price target raised to $85 from $84 at Deutsche Bank
CL Colgate-Palmolive
$83.49 /

+0.315 (+0.38%)

CL Colgate-Palmolive
$83.49 /

+0.315 (+0.38%)

CL Colgate-Palmolive
$83.49 /

+0.315 (+0.38%)

CL Colgate-Palmolive
$83.49 /

+0.315 (+0.38%)

Recommendations
Twitter price target raised to $70 from $65 at BMO Capital » 07:12
07/30/21
07/30
07:12
07/30/21
07:12
TWTR

Twitter

/

+

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
/

+

TWTR Twitter
/

+

07/29/21 Wells Fargo
Facebook price target raised to $450 from $415 at Wells Fargo
07/23/21 Jefferies
Twitter price target raised to $80 from $70 at Jefferies
07/23/21 Truist
Twitter price target raised to $80 from $70 at Truist
07/23/21 Oppenheimer
Twitter price target raised to $85 from $70 at Oppenheimer
TWTR Twitter
/

+

TWTR Twitter
/

+

TWTR Twitter
/

+

TWTR Twitter
/

+

Recommendations
Edwards Lifesciences price target raised to $115 from $93 at Wells Fargo » 07:12
07/30/21
07/30
07:12
07/30/21
07:12
EW

Edwards Lifesciences

$111.76 /

+1.65 (+1.50%)

Wells Fargo analyst Larry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

07:05 Today Deutsche Bank
Edwards Lifesciences price target raised to $113 from $84 at Deutsche Bank
05:21 Today Piper Sandler
Edwards Lifesciences price target raised to $123 from $120 at Piper Sandler
07/27/21 Piper Sandler
Edwards Lifesciences price target raised to $120 from $105 at Piper Sandler
07/23/21 Cowen
Edwards Lifesciences price target raised to $125 from $100 at Cowen
EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

Earnings
iRadimed sees 2021 adjusted EPS 60c-62c, two est. 53c » 07:12
07/30/21
07/30
07:12
07/30/21
07:12
IRMD

iRadimed

$34.60 /

-0.69 (-1.96%)

Sees revenue $40M-$40.4M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IRMD iRadimed
$34.60 /

-0.69 (-1.96%)

IRMD iRadimed
$34.60 /

-0.69 (-1.96%)

08/03/20 Roth Capital
iRadimed price target lowered to $26 from $30 at Roth Capital
IRMD iRadimed
$34.60 /

-0.69 (-1.96%)

Earnings
Newell Brands sees Q3 normalized EPS 46c-50c, consensus 55c » 07:12
07/30/21
07/30
07:12
07/30/21
07:12
NWL

Newell Brands

$27.23 /

+0.395 (+1.47%)

Sees Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

07/14/21 Raymond James
Newell Brands upgraded to Strong Buy from Market Perform at Raymond James
07/13/21 Raymond James
Newell Brands upgraded to Strong Buy from Market Perform at Raymond James
06/23/21 UBS
Newell Brands initiated with a Buy at UBS
05/03/21 Truist
Newell Brands price target raised to $35 from $30 at Truist
NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

Hot Stocks
Colgate-Palmolive reports adjusted gross profit margin 60%, down 80 bps  07:11
07/30/21
07/30
07:11
07/30/21
07:11
CL

Colgate-Palmolive

$83.49 /

+0.315 (+0.38%)

 
ShowHide Related Items >><<
CL Colgate-Palmolive
$83.49 /

+0.315 (+0.38%)

CL Colgate-Palmolive
$83.49 /

+0.315 (+0.38%)

06/23/21 UBS
Colgate-Palmolive initiated with a Buy at UBS
06/09/21
Fly Intel: Top five analyst upgrades
06/09/21 Credit Suisse
Colgate-Palmolive upgraded to Outperform from Neutral at Credit Suisse
05/03/21 Deutsche Bank
Colgate-Palmolive price target raised to $85 from $84 at Deutsche Bank
CL Colgate-Palmolive
$83.49 /

+0.315 (+0.38%)

CL Colgate-Palmolive
$83.49 /

+0.315 (+0.38%)

CL Colgate-Palmolive
$83.49 /

+0.315 (+0.38%)

CL Colgate-Palmolive
$83.49 /

+0.315 (+0.38%)

Recommendations
MasterCard price target raised to $440 from $430 at Wells Fargo » 07:11
07/30/21
07/30
07:11
07/30/21
07:11
MA

MasterCard

$388.87 /

+5.39 (+1.41%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MA MasterCard
$388.87 /

+5.39 (+1.41%)

MA MasterCard
$388.87 /

+5.39 (+1.41%)

07/28/21 Susquehanna
JetBlue price target lowered to $21 from $24 at Susquehanna
07/15/21 Evercore ISI
MasterCard added to Tactical Outperform List at Evercore ISI
07/15/21 Baird
MasterCard price target raised to $482 from $454
07/15/21 Baird
MasterCard price target raised to $482 from $454
MA MasterCard
$388.87 /

+5.39 (+1.41%)

MA MasterCard
$388.87 /

+5.39 (+1.41%)

MA MasterCard
$388.87 /

+5.39 (+1.41%)

MA MasterCard
$388.87 /

+5.39 (+1.41%)

Earnings
Newell Brands reports Q2 normalized EPS 56c, consensus 45c » 07:11
07/30/21
07/30
07:11
07/30/21
07:11
NWL

Newell Brands

$27.23 /

+0.395 (+1.47%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

07/14/21 Raymond James
Newell Brands upgraded to Strong Buy from Market Perform at Raymond James
07/13/21 Raymond James
Newell Brands upgraded to Strong Buy from Market Perform at Raymond James
06/23/21 UBS
Newell Brands initiated with a Buy at UBS
05/03/21 Truist
Newell Brands price target raised to $35 from $30 at Truist
NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

NWL Newell Brands
$27.23 /

+0.395 (+1.47%)

Earnings
iRadimed sees Q3 adjusted EPS 16c-17c, two est. 13c » 07:11
07/30/21
07/30
07:11
07/30/21
07:11
IRMD

iRadimed

$34.60 /

-0.69 (-1.96%)

Sees Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRMD iRadimed
$34.60 /

-0.69 (-1.96%)

IRMD iRadimed
$34.60 /

-0.69 (-1.96%)

08/03/20 Roth Capital
iRadimed price target lowered to $26 from $30 at Roth Capital
IRMD iRadimed
$34.60 /

-0.69 (-1.96%)

Hot Stocks
Enbridge still sees FY21 EBITDA $13.9B-$14.3B » 07:10
07/30/21
07/30
07:10
07/30/21
07:10
ENB

Enbridge

$39.70 /

+0.36 (+0.92%)

Still sees FY21…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENB Enbridge
$39.70 /

+0.36 (+0.92%)

ENB Enbridge
$39.70 /

+0.36 (+0.92%)

07/20/21 Barclays
Enbridge downgraded to Equal Weight from Overweight at Barclays
07/08/21 Scotiabank
Enbridge price target raised to C$55 from C$54 at Scotiabank
06/30/21 Goldman Sachs
Enbridge upgraded to Neutral from Sell at Goldman Sachs
06/18/21 CIBC
Enbridge price target raised to C$57 from C$52 at CIBC
ENB Enbridge
$39.70 /

+0.36 (+0.92%)

ENB Enbridge
$39.70 /

+0.36 (+0.92%)

ENB Enbridge
$39.70 /

+0.36 (+0.92%)

Recommendations
Mettler-Toledo price target raised to $1455 from $1303 at Baird » 07:10
07/30/21
07/30
07:10
07/30/21
07:10
MTD

Mettler-Toledo

$1,508.23 /

+7.56 (+0.50%)

Baird analyst Catherine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTD Mettler-Toledo
$1,508.23 /

+7.56 (+0.50%)

MTD Mettler-Toledo
$1,508.23 /

+7.56 (+0.50%)

04/07/21 Baird
Mettler-Toledo assumed with an Outperform at Baird
02/05/21 Wells Fargo
Mettler-Toledo price target raised to $1,300 from $1,100 at Wells Fargo
01/04/21
Fly Intel: Top five analyst upgrades
01/04/21
Mettler-Toledo upgraded to In Line at Evercore ISI given strong rebound history
MTD Mettler-Toledo
$1,508.23 /

+7.56 (+0.50%)

MTD Mettler-Toledo
$1,508.23 /

+7.56 (+0.50%)

MTD Mettler-Toledo
$1,508.23 /

+7.56 (+0.50%)

Earnings
Hill-Rom raises FY21 adjusted EPS view to $6.08-$6.12 from $ 6.00-$6.10 » 07:09
07/30/21
07/30
07:09
07/30/21
07:09
HRC

Hill-Rom

$136.86 /

+4.17 (+3.14%)

Consensus $6.06. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

07/29/21 KeyBanc
KeyBanc sees a potential acquisition of Hill-Rom 'favorably' for Baxter
07/28/21 KeyBanc
Baxter offer in $150-$165 range would be 'reasonable' for Hill-Rom, says KeyBanc
05/03/21 Baird
Hill-Rom price target raised to $125 from $115 at Baird
02/08/21 Baird
Hill-Rom price target raised to $115 from $105 at Baird
HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

Earnings
iRadimed reports Q2 adjusted EPS 14c, two est. 9c » 07:09
07/30/21
07/30
07:09
07/30/21
07:09
IRMD

iRadimed

$34.60 /

-0.69 (-1.96%)

Reports Q2 revenue $9.8M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRMD iRadimed
$34.60 /

-0.69 (-1.96%)

IRMD iRadimed
$34.60 /

-0.69 (-1.96%)

08/03/20 Roth Capital
iRadimed price target lowered to $26 from $30 at Roth Capital
IRMD iRadimed
$34.60 /

-0.69 (-1.96%)

Earnings
Enbridge reports Q2 adjusted EPS 67c, consensus 55c » 07:09
07/30/21
07/30
07:09
07/30/21
07:09
ENB

Enbridge

$39.70 /

+0.36 (+0.92%)

CEO Al Monaco stated,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENB Enbridge
$39.70 /

+0.36 (+0.92%)

ENB Enbridge
$39.70 /

+0.36 (+0.92%)

07/20/21 Barclays
Enbridge downgraded to Equal Weight from Overweight at Barclays
07/08/21 Scotiabank
Enbridge price target raised to C$55 from C$54 at Scotiabank
06/30/21 Goldman Sachs
Enbridge upgraded to Neutral from Sell at Goldman Sachs
06/18/21 CIBC
Enbridge price target raised to C$57 from C$52 at CIBC
ENB Enbridge
$39.70 /

+0.36 (+0.92%)

ENB Enbridge
$39.70 /

+0.36 (+0.92%)

ENB Enbridge
$39.70 /

+0.36 (+0.92%)

Periodicals
Tesla Megapack caught fire at Australia battery project, Electrek reports » 07:09
07/30/21
07/30
07:09
07/30/21
07:09
TSLA

Tesla

$677.35 /

+30.54 (+4.72%)

A Tesla Megapack part of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$677.35 /

+30.54 (+4.72%)

TSLA Tesla
$677.35 /

+30.54 (+4.72%)

07/29/21 DZ Bank
Tesla upgraded to Buy from Sell at DZ Bank
07/28/21 Citi
Tesla price target raised to $209 from $175 at Citi
07/27/21 Needham
Tesla saw improvement on cost structure, valuation still too high, says Needham
07/27/21 Roth Capital
Competitive news flow likely drives Tesla 2H21 volatility, says Roth Capital
TSLA Tesla
$677.35 /

+30.54 (+4.72%)

TSLA Tesla
$677.35 /

+30.54 (+4.72%)

TSLA Tesla
$677.35 /

+30.54 (+4.72%)

TSLA Tesla
$677.35 /

+30.54 (+4.72%)

Recommendations
Gilead price target raised to $84 from $81 at RBC Capital » 07:09
07/30/21
07/30
07:09
07/30/21
07:09
GILD

Gilead

$69.83 /

-0.28 (-0.40%)

RBC Capital analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$69.83 /

-0.28 (-0.40%)

GILD Gilead
$69.83 /

-0.28 (-0.40%)

06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/01/21
Fly Intel: Top five analyst upgrades
GILD Gilead
$69.83 /

-0.28 (-0.40%)

GILD Gilead
$69.83 /

-0.28 (-0.40%)

GILD Gilead
$69.83 /

-0.28 (-0.40%)

GILD Gilead
$69.83 /

-0.28 (-0.40%)

Hot Stocks
Capital Product Partners says supply of vessels continues to be very restricted » 07:08
07/30/21
07/30
07:08
07/30/21
07:08
CPLP

Capital Product Partners

$12.21 /

+0.3 (+2.52%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPLP Capital Product Partners
$12.21 /

+0.3 (+2.52%)

CPLP Capital Product Partners
$12.21 /

+0.3 (+2.52%)

04/30/21 B. Riley
Capital Product Partners price target raised to $16 from $14 at B. Riley
04/22/21 Jefferies
Jefferies upgrades Capital Product Partners on rising containership values
04/22/21 Jefferies
Capital Product Partners upgraded to Buy from Hold at Jefferies
04/05/21 B. Riley Securities
Capital Product price target raised to $14 from $11 at B. Riley
CPLP Capital Product Partners
$12.21 /

+0.3 (+2.52%)

Earnings
Capital Product Partners reports Q2 EPS $1.89, consensus 55c » 07:07
07/30/21
07/30
07:07
07/30/21
07:07
CPLP

Capital Product Partners

$12.21 /

+0.3 (+2.52%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CPLP Capital Product Partners
$12.21 /

+0.3 (+2.52%)

CPLP Capital Product Partners
$12.21 /

+0.3 (+2.52%)

04/30/21 B. Riley
Capital Product Partners price target raised to $16 from $14 at B. Riley
04/22/21 Jefferies
Jefferies upgrades Capital Product Partners on rising containership values
04/22/21 Jefferies
Capital Product Partners upgraded to Buy from Hold at Jefferies
04/05/21 B. Riley Securities
Capital Product price target raised to $14 from $11 at B. Riley
CPLP Capital Product Partners
$12.21 /

+0.3 (+2.52%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.